ADMS - Adamas Pharmaceuticals Inc. (ADMS) CEO Greg Went on Q4 2018 Results - Earnings Call Transcript
Adamas Pharmaceuticals, Inc. (ADMS)
Q4 2018 Earnings Conference Call
March 4, 2019 4:30 p.m. ET
Company Participants
Greg Went - Chairman and CEO
Alf Merriweather - CFO
Rajiv Patni - Chief Medical Officer
Conference Call Participants
David Amsellem - Piper Jaffray
Tim Lugo - William Blair
Ken Cacciatore - Cowen & Company
Tazeen Ahmad - Bank of America Merrill Lynch
Marc Goodman - SVB Leerink
Ram Selvaraju - H.C. Wainwright
Serge Belanger - Needham & Company
Irina Koffler - Mizuho Securities
Presentation
Operator
Good day, ladies and gentlemen, and thank you for standing by. Welcome